US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Baudax Bio Inc/

Recent news which mentions Baudax Bio Inc/

Lab Notes: Janssen Biotech signs multimillion-dollar cell therapy collaboration and licensing deal
Tickers INNO
Tags MIneralys Therapeutics Charles Simmons Sen Zhuang
From Business Journals
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags Baudax Bio Inc/ Incyte Corp/ GlaxoSmithKline PLC
From Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
Tickers INNO
Tags Hervé Hoppenot Gerri Henwood Biotech
From Business Journals
Baudax Bio stock price plummets after firm announces $6.2M public offering
Tags Baudax Bio Inc/ Gerri Henwood Biotech
From Business Journals
Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy
Tickers INNO
Tags Antony Koblish Baudax Bio Inc/ Biotech
From Business Journals
Lab Notes: Spirovant opens new HQ; XyloCor advances gene therapy for heart ailment
Tickers INNO
Tags Al Gianchetti Joan Lau Medical Devices
From Business Journals
Lab Notes: Optinose advances sinusitis drug-device combo; WuXi launches new technology
Tickers INNO
Tags Ryan Cawood Baudax Bio Inc/ Prelude Therapeutics Incorporated
From Business Journals
Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
Tickers INNO
Tags Madrigal Pharmaceuticals Inc/ Coronavirus Biotech
From Business Journals